Degenerative Consequences of Congenital Deafness

April 6, 2023 updated by: Heather Wright, East Carolina University
In this study, the investigators will study one of the basic biophysical properties of the auditory nerve, charge integration, behaviorally (detection threshold versus phase duration functions). The investigators will compare charge integration in two subject groups: congenitally deafened and deafened at a later age in life. The investigators will then examine if behaviorally estimated neural excitation patterns differ between short phase duration and long phase duration stimulation. Lastly, The investigators will measure if speech recognition improves with using long phase duration stimulation, relative to using the standard default short phase duration stimulation. The primary endpoint of the study is speech recognition, and the secondary endpoints are the steepness of the detection threshold versus phase duration functions, and the width of psychophysically estimated neural excitation.

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

34

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Greenville, North Carolina, United States, 27834
        • Department of Communication Sciences and Disorders, ECU

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Children and adults with cochlear implants (Advanced Bionics and Cochlear Nucleus devices)

Description

Inclusion Criteria:

  • Cochlear Nucleus cochlear implant users or Advanced Bionics cochlear implant users
  • Native speakers of English
  • Early onset of deafness (< 3 years of age); no requirement for age at implantation
  • Late onset of deafness (> 3 years of age); matched in duration of deafness to the early onset group
  • Has had device experience for at least one year
  • Can be child or adult at the time of enrollment

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Cochlear implant users with late-onset deafness

Examine charge integration (Detection threshold as a function of phase duration).

Examine neural spatial excitation patterns with long and short phase duration. Measure speech recognition using long and short phase duration stimulation patterns.

We will vary the phase duration in the stimulation, and examine detection threshold, spatial spread of neural excitation, and speech recognition as the outcomes.
Cochlear implant users with early-onset deafness

Examine charge integration (Detection threshold as a function of phase duration) and compare that with the late-onset group.

Examine neural spatial excitation patterns with long and short phase duration within the non-leaky phase duration range.

Measure speech recognition using long and short phase duration stimulation patterns.

We will vary the phase duration in the stimulation, and examine detection threshold, spatial spread of neural excitation, and speech recognition as the outcomes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Slope of the strength duration function
Time Frame: starting 6 months post award notice and will take up to 4 years to complete
Subjects will be measured for detection thresholds as a function of phase duration of the pulse train and the slope of the function will be derived.
starting 6 months post award notice and will take up to 4 years to complete

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychophysically estimated neural excitation width
Time Frame: starting 6 months post award notice and will take up to 4 years to complete
Subjects will be measured for psychophysical forward-masked spatial tuning curves using stimuli with long and short phase duration.
starting 6 months post award notice and will take up to 4 years to complete
Speech recognition using long phase duration
Time Frame: starting 6 months post award notice and will take up to 4 years to complete
Subjects' speech recognition performance will be evaluated using CUNY and TIMIT sentences with long and short phase duration stimulation.
starting 6 months post award notice and will take up to 4 years to complete

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2019

Primary Completion (Actual)

April 4, 2023

Study Completion (Actual)

April 4, 2023

Study Registration Dates

First Submitted

March 5, 2019

First Submitted That Met QC Criteria

March 6, 2019

First Posted (Actual)

March 7, 2019

Study Record Updates

Last Update Posted (Actual)

April 7, 2023

Last Update Submitted That Met QC Criteria

April 6, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Congenital Deafness

Clinical Trials on Phase duration

3
Subscribe